Investigation of the signature of recurrence and radiation effects after External-Beam Radiotherapy of prostate cancer on multi-parametric MRI

Investigation of the signature of recurrence and radiation effects after External-Beam Radiotherapy of prostate cancer on multi-parametric MRI - MRI at +/- recurrent prostate cancer patients after EBRT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON43978

Enrollment

Registered

2016-06-15

Start date

2015-12-17

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

multi-parametric MRI

prostate cancer

radiotherapy

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: case group:- Biochemical failure, more than 24 months after completion of prior EBRT for treatment of prostate cancer;control group: - Completion of prior EBRT for treatment of prostate cancer more than 24 months ago without biochemical failure

Exclusion criteria

Exclusion criteria: - Hormonal treatment in the past year - Patients who use anticoagulants and can not stop this temporarily for taking biopsies - Contra-indications for an MRI exam according to the standard protocol for the screening of patients with prostate cancer - Other treatments for cancer in the pelvis

Design outcomes

Primary

Measure	Time frame
Investigate the signature of recurrent prostate cancer and of radiation effects after external-beam radiotherapy on multi-parametric MRI	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)